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role of capillaries is to serve as the interface for delivery of oxygen and removal of
metabolites to/from tissues. During the past decade there has been a proliferation of
studies that have advanced our understanding of angiogenesis, demonstrating that
tissue capillary supply is under strict control during health but poorly controlled in
disease, resulting in either excessive capillary growth (pathological angiogenesis)
or losses in capillarity (rarefaction). Given that skeletal muscle comprises nearly
40% of body mass in humans, skeletal muscle capillary density has a significant
impact on metabolism, endocrine function, and locomotion and is tightly regulated
at many different levels. Skeletal muscle is also high adaptable and thus one of the
few organ systems that can be experimentally manipulated (e.g., by exercise) to
study physiological regulation of angiogenesis. This review will focus on the
methodological concerns that have arisen in determining skeletal muscle capillarity
and highlight the concepts that are reshaping our understanding of the angio-
adaptation process. We also summarize selected new findings (physical influences,
molecular changes, and ultrastructural rearrangement of capillaries) that identify
areas of future research with the greatest potential to expand our understanding of
how angiogenesis is normally regulated, and that may also help to better understand
conditions of uncontrolled (pathological) angiogenesis.
exercise; human; rodent; training
THIS ARTICLE is part of a collection on Pan American Congress
of Physiological Sciences Meeting 2014. Other articles ap-
pearing in this collection, as well as a full archive of all
collections, can be found online at http://ajpheart.physiology.
org/.
Introduction
There is wide recognition (17, 38, 126) and a surfeit of
epidemiologic evidence that links the benefits of exercise
training with a decreased risk of cardiovascular diseases. The
reasons are manifold, but one important factor is that the
peripheral microvasculature adapts in structure and function to
this stimulus. The role of the microcirculation, in particular of
the capillaries, is to serve as the interface for delivery of
oxygen and removal of metabolites to/from tissues. In this
context, the assumption has always been that “more is better”
and that greater capillary surface area results in increased
potential for diffusion of oxygen and metabolite clearance,
thereby improving endurance and aerobic capacity (65). In-
deed, the literature supports a correlation between capillary
density (CD) and the proportion of oxidative fibers or average
mitochondrial volume density among different skeletal mus-
cles (63), and exercise performance or maximal aerobic capac-
ity correlate well with skeletal muscle CD in animals (65).
Given that skeletal muscle comprises nearly 40% of body
mass in humans, altering muscle CD has a significant impact
on metabolism, endocrine function, and locomotion. Whereas
an increased skeletal muscle CD likely indicates capillary
growth (angiogenesis) linked with functional improvements,
decreased skeletal muscle CD (i.e., capillary rarefaction) is
associated with poor health outcomes and declining prognosis
in association with many chronic diseases, such as peripheral
arterial disease (77, 87), diabetes (79, 80), cachexia (7), and
chronic obstructive pulmonary disease (74). It is therefore
important to understand the mechanisms involved in the reg-
ulation of muscle capillaries to both optimize physiological
outcomes and ameliorate pathological consequences.
In contrast to vasculogenesis, which is the de novo forma-
tion of blood vessels essential in the initial development of the
microcirculation in embryos, angiogenesis is the formation of
capillaries from existing blood vessels. Angiogenesis plays a
key role throughout all stages of life (e.g., tissue injury/wound
repair, the endometrial cycle, and striated muscle adaptation to
stress/exercise). During the past decade there has been a
proliferation of studies that have advanced our understanding
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of the angiogenic processes, demonstrating that capillary
growth in skeletal muscle is a process that is tightly regulated
at many different levels [see reviews (29, 59, 101)]. This
regulation follows the principles of a control circuit. For
example, when the microcirculation is inadequate to fully meet
the metabolic demands imposed on the muscle by cellular and
physical influences (see below), these influences exert an
upstream effect on the capillary network to proliferate (up-
stream input). The physical influence(s) are sensed by muscle
fibers and endothelial cells (ECs) and translated into an appro-
priate gene expression profile (control variable), which ulti-
mately alter the EC phenotype (downstream output) and lead to
capillary growth. Angiogenesis is thought to terminate once
metabolic homeostasis is reestablished (feedback). This, how-
ever, is a multifactorial and highly orchestrated process for
which we are only beginning to understand the molecular
underpinnings.
This review will focus on the methodology to determine CD
and highlight the concepts in health and disease that are
reshaping our understanding of the angioadaptation process.
We will use an integrative review to assess the impact of, but
also responses to, altered muscle activity and summarize se-
lected new findings that identify areas of future research with
the greatest potential to expand our understanding of the
regulation of skeletal muscle angiogenesis and thus improve
therapeutic efficacy.
Methodology
As the number of studies on skeletal muscle angiogenesis
continues to grow, it is increasingly important to have consis-
tency and methodological commonality in quantitative deter-
mination of CD, to avoid confounding technical and analytical
issues that can produce ambiguous results. Among the issues to
consider are 1) the direction of skeletal muscle sectioning–it is
critically important to have a reference orientation, but this is
sometimes neglected; 2) appropriate structural indicators for
characterization of capillarity; and 3) regional heterogeneity of
fiber type and therefore muscle capillarity within a given
muscle, which can lead to unintentional bias in the capillary
data reported. The latter is perhaps most widely recognized
within the gastrocnemius (15) and tibialis anterior muscles
(which are well known “mixed muscle” phenotypes), but all
skeletal muscle exhibit varying degrees of muscle fiber type
and capillary heterogeneity (5, 27, 30, 111).
Skeletal muscle is an anisotropic tissue, meaning its major
cellular components are not randomly arranged. The microvas-
culature run largely in parallel with the longitudinal axis of
muscle fibers. However, the two entities may be loosely con-
nected, with capillaries meandering over the surface of fibers
(Fig. 1A). Hence, a potentially greater functional relevant index
may be achieved by calculating capillary length density [the
length of capillaries per unit volume of muscle fibers, in
stereological terminology denoted as JV(c,f)], as this takes into
account the additional surface area of each capillary offered by
greater tortuosity (91). This is 7–64% higher than that esti-
mated from CD alone in transverse tissue sections due to the
tortuosity and branching anastomoses seen in skeletal muscles
(90, 91). However, such quantification requires a more time-
consuming and technically demanding methodology than rou-
tine estimates of CD, so unfortunately it is not commonly
performed. When only muscle cross sections are evaluated, as
is most often the case, appropriate values are most readily
obtained with true transverse sections (i.e., perpendicular to the
muscle fiber axis, as shown in Fig. 1B). It is important to avoid
oblique sections, which lead to erroneously high-fiber area
and/or counting multiple points of the same tortuous capillary
undulating in and out of the horizontal plan of the muscle
section. However, it should be noted that with an appropriate
sampling design, it is possible to get estimates of CD from
longitudinal sections, but this too is not often performed.
The number of muscle fiber and capillary profiles within a
given area can be used to calculate the numerical capillary-to-
fiber ratio (C:F) [in stereological notation, NN(c,f)]. This
should not be confused with the number of capillaries sur-
rounding individual fibers [i.e., N(c,f) or NCAF] or the derived
index of capillary contacts, which are both quite insensitive to
changes during tissue remodeling and hence have limited
utility as a quantitative index of angiogenesis (30). In addition,
the number of capillary profiles per cross-sectional area of
muscle fibers is used to determine the CD [i.e., capillaries
mm2]. This measure is also frequently referred to as mi-
crovessel density, which can add ambiguity to the literature
when studies include terminal arterioles and collecting venules
within this definition. In stereological terms CD is denoted as
NA(c,f) in striated muscle and provides a useful index of the
functional capillary supply. However, it is important to recog-
nize that CD depends on the mean cross-sectional area of
muscle fibers. As mean cross-sectional area of muscle fibers is
often modulated in response to changes in physical demand or
the metabolic environment, CD should not be relied on as the
sole metric used to quantify the extent of angiogenesis. Rather,
inclusion of the C:F is often recommended since it is less
sensitive to the issue of scaling (32).
Finally, skeletal muscle displays a varying degree of fiber-
type heterogeneity that can have a direct and significant influ-
ence on the quantitative assessment of muscle capillarity in-
dexes. For example, the gastrocnemius and tibialis anterior
muscles are frequently studied because of their active role in
locomotion and exercise. But these and other skeletal muscle
represent a “mixed” muscle type containing a heterogeneous
distribution of myofiber phenotypes (27, 116) with concomi-
tant regional heterogeneity in capillary supply (Fig. 2). Thus
Fig. 1. Light microscopic representation of capillaries in skeletal muscle. A:
60-m-thick longitudinal section of a porcine skeletal muscle injected with
colored gelatin. Note the tortuous course of the capillaries (arrows) and
anastomoses (asterisks). B: light microscopic representation of a 10-m-thick
cryosection from a mouse extensor digitorum longus subjected to alkaline
phosphatase histochemistry. The capillaries are visualized as black dots (ar-
rows) surrounding the skeletal muscle fibers.
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rigorous procedural attention is required when selecting histo-
logical images for counting to avoid sampling bias within any
muscle sample. Indeed, unbiased counting rules defining ran-
domness of sampling and counting procedures are essential and
obviate the need to analyze the entire muscle when the rules of
stereology are strictly followed (31, 34).
Physical Influences
Physiological regulation of CD (i.e., during adaptive remod-
eling) involves a significant influence of the physical environ-
ment (Fig. 3). For example, mechanical factors such as in-
creased shear stress exerted on the capillary lumen by func-
tional hyperemia, or elevated tissue strain as a consequence of
repetitive contraction/relaxation cycles may stimulate capillary
growth in both cardiac and skeletal muscle (65).
The in vivo control of angiogenesis involves a complex
array of stimuli and an ever-growing multifactorial list of
candidates associated with muscle exercise activity [see re-
views (29, 59, 101)], which invites a reductionist approach to
better define potential contributors. Functional hyperemia in-
creases microvascular shear stress (because of low compliance
of capillaries) and chronically elevated blood flow is capable of
inducing angiogenesis in the absence of any change in muscle
phenotype, which demonstrates a potential disconnection be-
tween the cellular feedback from host tissue that has usually
been deemed essential for angiogenesis. For example, when
muscles were exposed to targeted hindlimb dilatation, raising
average capillary wall shear stress by nearly fourfold, there
was a 30% increase in C:F (24).
At rest, blood flow to skeletal muscle is low, but during
contractile activity, it can be enhanced up to 100-fold to
accommodate the large increase in oxygen demand (3). Blood
flow to the muscle is determined by perfusion pressure and
vascular conductance. The latter is well balanced and regulated
by sympathetic vasoconstriction, sympatholytic compounds,
and vasodilators, which are locally produced in the muscle
(primarily by EC, red blood cells, and skeletal muscle fibers).
Regulation of vascular conductance involves flow-mediated,
conducted, and red blood cell-mediated dilatation, as well as
interaction between several vasodilators, including nitric oxide
(NO), prostacyclin, adenosine, and ATP (114). NO and pros-
taglandins have been found to be central in blood flow regu-
lation, as the vasodilatory effect of many other compounds
(e.g., acetylcholine, adenosine, ATP, and bradykinin) as well
as mechanical signals (shear stress) are mediated through the
formation of these compounds (55). The vascular system is
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Fig. 2. Capillary and fiber-type heterogeneity within skeletal muscle. Depicted here is capillary heterogeneity within the gastrocnemius (A) and extensor digitorum
longus (B) skeletal muscle. A: montage of 5 overlapping images obtained using light microscopy (5) to depict the entire transverse (or horizontal) view of a
single mouse gastrocnemius muscle stained with alkaline phosphatase (capillaries appear as dark spots within the muscle section). Scale bar 400 m. B: images
obtained using light microscopy (20) from transverse section of mouse extensor digitorum longus muscle. B, left: images stained with rhodamine-labeled lectin
(capillaries appear as bright spots within the muscle section). B, right: adjacent images stained for fiber types (and which are obtained from same region
corresponding to images at left). Immunolabeling reveals fibers appearing black (dark) are type IIB, green-appearing fibers are type IIA, and orange-colored fibers
are type I. Blue stain is laminin used to delineate fiber boundaries. A & B: significant heterogeneity in muscle capillarity depending on region of sampling within
a muscle and that (as seen in B) this heterogeneity corresponds to muscle fiber-type heterogeneity found in muscles with mixed fiber-type composition. Scale
bar  200 m. (Kissane and Egginton, unpublished.)
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therefore particularly sensitive to alterations in NO and pros-
taglandin bioavailability. This may be particularly important in
the context of capillary adaptation, since negative angiogenic
regulators, such as thrombospondin-1 (TSP-1), which is dis-
cussed later, are also known to inhibit NO activity (71, 109).
The large increase in blood flow to muscle during exercise
will induce a significant increase in shear stress in the capillary
bed and thereby promote angiogenesis. Similarly, several va-
sodilators (including NO, prostaglandins, and adenosine) are
also implicated in the regulation of muscle angiogenesis (1, 8,
106), e.g., NO simultaneously induces vasodilatation and en-
hances vascular endothelial growth factor (VEGF) expression
(11). Not surprisingly, there is a close association between the
magnitude of blood flow in tissues and the level of capillar-
ization (127). In addition to the usual increase in VEGF, high
shear stress also leads to upregulation of endothelial NO
synthase (eNOS) mRNA and protein expression, possibly lead-
ing to feedback promotion of VEGF expression (8). However,
the level of shear stress induced by pharmacological vasodila-
tation is likely in excess of that associated with functional
hyperemia induced by electrical stimulation in rodents. But, it
must be noted that direct measurements of capillary shear
stress during exercise in humans are lacking.
Muscle stretch, either during normal duty cycle or overload
(induced with synergistic muscle extirpation), is also a potent
angiogenic stimulus accompanying muscle hypertrophy (25,
121). In resistance training mitochondrial volume density de-
creases in proportion to muscle hypertrophy, whereas with
stretch, capillary supply increases in response to an anabolic
(aerobic) environment caused by imposition of a sustained
strain of 20%, where C:F increased by some 45% (131). In this
case higher VEGF levels were accompanied by elevated matrix
metalloproteinase (MMP) activity associated with extracellular
matrix remodeling (49). Interestingly, MMP inhibition pre-
vented EC migration but not proliferation during muscle stim-
ulation, demonstrating differential control over individual ele-
ments of the angiogenic cascade (32).
Indirect electrical stimulation of skeletal muscle is one of the
most potent angiogenic stimuli known, and in rodent hindlimb
extensors, it can increase C:F by 50% (36). In this experimental
model, the multifactorial consequences of such activity–hemo-
dynamic forces (shear stress, transmural pressure) and dynamic
duty cycles (muscle stretch and compression)–initiate remod-
eling of the vasculature by activating endothelial mechano-
transduction mechanisms. These are likely mediated by integ-
rins and associated GTPases. Subsequent signal transduction
acts through phosphorylation of kinases (e.g., FAK, c-Src, Akt
kinase, phosphatidylinositol 3-kinase, MLCK, and MAPK) to
elicit a response appropriate to the stimulus and tissue (29). But
it should also be noted that electrical stimulation and its
indirect effect of increasing shear stress can result in damage to
the luminal glycocalyx that may also potentiate the endothelial
response (32). Nevertheless, it is thought that the angiogenic
stimuli elicited via electrical stimulation is likely the most
similar to that experienced during endurance exercise.
There is great potential to exploit these findings in develop-
ing specific angiotherapies, in particular the differential re-
sponse of muscle and microcirculation. However, there is a
growing awareness of the need to better understand the time
course of adaptation and/or the intensity of the stimulus. For
example, whereas forced treadmill running typically requires at
least 6 wk to elicit a significant increase in skeletal muscle
angiogenesis, voluntary wheel running in mice has been shown
to increase skeletal muscle CD starting after only 5–7 days
(99). Likewise, functional hyperemia and overload stimuli
achieve similar responses in 2 wk, whereas electrical stimula-
tion can do so in only 1 wk (32). Based on data from whole
body exercise, it is becoming evident that the volume of
exercise (i.e., time spent exercising) also has an influence
capillary adaptation that is currently underappreciated. For
example, rodents given access to running wheels voluntarily
run between 5–10 km/day and rarely exceed 25% of their
maximal effort, but yet achieve capillary expansion rapidly
(i.e., 5–7 days). In contrast, forced treadmill running regimes
typically attain 2 km/day but often impose exercise above
50% of maximum effort and usually take 6 wk or more for
changes in muscle capillarity to occur. These data suggest that
the combination of high-volume, low-intensity exercise (i.e.,
voluntary wheel running) elicits a quicker angioadaptive re-
sponse than that occurring with low-volume, high-intensity
exercise programs. Similar time course experiments are not
available in humans, but training studies involving different
Fig. 3. Overview of the physical and metabolic stimuli contributing to angio-
genesis in skeletal muscle in response to endurance exercise. Exercise leads to
an increase in blood flow through capillaries (functional hyperemia), as well as
metabolic and mechanical (physical) alterations of the skeletal muscle fibers
that may modulate the gene expression patterns of angiogenic factors, and
subsequently, change the capillary ultrastructure (e.g., pericytes, protrusions,
etc.) that determines angiotype (e.g., splitting and sprouting angiogenesis) in
skeletal muscle. Solid lines (–––) represent the physical stimuli that are
believed to influence exercise-induced skeletal muscle angiogenesis. Dashed lines
(  ) represent metabolic stimuli that have also been reported to have
either primary or secondary influences on exercise-induced skeletal muscle
angiogenesis. Dotted green lines (···) represent the potential sources releasing
molecular factors responsible for angiogenesis. eNOS, endothelial nitric oxide
(NO) synthase; MMP, matrix metalloproteinase; TSP-1, thrombospondin-1.
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exercise intensities indicate that the angiogenic response to a
period of training at moderate intensity is similar to that of
high-intensity training in previously untrained individuals (21,
60, 72). However, there are indications that very high-intensity
training can actually lead to a negative effect on VEGF levels
(43, 61). In addition, the recognition that mechanical factors
may play as potent a role in microvascular remodeling as
chemical or metabolic factors (such as local tissue hypoxia,
acidosis, glucose, etc.) has led to the concept of “passive”
training, which shows an elevation of angiogenic factor ex-
pression in muscle without active work being performed (56).
Thus it is tempting to speculate that low-intensity, high-volume
exercise regimes may produce a stronger angiogenic stimulus
and perhaps use intussusception/longitudinal splitting (i.e., a
mode of angiogenesis with less energetic requirements com-
pared with sprouting, discussed further in following section)
and therefore result in more rapid capillary adaptation com-
pared with capillary sprouting (that is expected from high-
intensity, low-volume exercise frequently used with forced
treadmill running in rodents). At present, however, the poten-
tial differential stimuli and associated molecular responses
between exercise modalities are still only poorly understood
and will require more deliberate investigation to unravel.
Indeed, future studies aimed at directly assessing these re-
sponses are needed, as they may also help to devise and
improve modes of exercise to maximize the benefits from
rehabilitation therapies in the clinic.
Capillary Ultrastructure
Endothelial cells. Microvessel in skeletal muscles manifest a
characteristic ultrastructure, which is best seen by transmission
electron microscopy. Shown in Fig. 4 is a transmission electron
microscopy image where the outer (abluminal) surface of
capillary ECs is covered by a dense basement membrane
frequently containing profiles of one or more perivascular
pericytes. It is interesting to note, this image appears to show
that both cell types communicate extensively during angiogen-
esis (9, 66). In response to elevated luminal shear stress
(prazosin-treated rats), a higher proportion of intraluminal
irregularities, projections, and septa combined with extensive
cytoplasmic vacuolization of EC were observed in skeletal
muscle capillaries, which are interpreted as signs of a longitu-
dinal splitting form of angiogenesis with little evidence for EC
proliferation (130). When the canonical sprouting angiogenesis
was induced in rats by increased stretch of skeletal muscles due
to overload (131) or during chronic electrical stimulation (51),
the proportion of abluminal sprouts was higher in capillaries
during active angiogenesis, whereas the labeling index (bro-
modeoxyuridine incorporation) was higher than in the control
animals, suggesting that this angiotype is associated with
proliferation of ECs (131). In addition, endurance exercise is
accompanied by thinning of the pericapillary basement mem-
brane (125), which is presumably induced by the higher ex-
pression/activity of MMPs and their proteolytic actions (110).
Indeed, in studies with rodents, hallmarks for changes in the
ultrastructural phenotype of capillaries in response to angio-
genic stimuli have been identified (36).
While the sprouting form of angiogenesis is characterized by
hallmarks of EC proliferation and migration (110), nonsprout-
ing angiogenesis can be divided into 1) longitudinal splitting,
involving cytoplasmic invagination and bridging over the lu-
men, and 2) intussusception that occurs with infiltration of
stromal cells (36). It is thought that as nonsprouting angiogen-
esis involves a much lower extent of EC proliferation, this may
be an energetically efficient and potentially more rapid way of
extending the microcirculation.
Surprisingly, it has not yet been determined whether sprout-
ing or splitting/intussusception is used to realize physiological
angiogenesis in skeletal muscles in response to exercise or
whether this could explain the temporal difference in capillary
adaptation between voluntary wheel running versus forced
treadmill exercise. It is interesting to note that EC production
of VEGF appears not to be essential to elicit angiogenesis,
since selective deletion of VEGF in ECs does not appear to
alter CD in a variety of organs (83). However, it should be
emphasized that tight regulation of angiogenic activity still
requires involvement of EC, as well as influence of perivascu-
lar cell types within the interstitium. Indeed, this cell-cell
contact suggests other signaling routes may be operative (32),
perhaps in the context of basement membrane remodeling,
potentially balancing activity of angiogenic inhibitors and
stimulators.
Pericytes. Because of their close spatial relationship to ECs,
it was speculated that pericytes contribute to the regulation of
Fig. 4. Characteristic ultrastructure of a capillary from human
(A) and mouse (B) skeletal muscles depicted by transmission
electron microscopy. In general, capillaries from humans are
larger, exhibit a thicker basement membrane (BM), and form
less filopoda than those from mice. EC, endothelial cell; PC,
pericytes. Same scale applies to both images.
Review
H330 SKELETAL MUSCLE ANGIOGENESIS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00635.2015 • www.ajpheart.org
angiogenesis (41, 57), involving a combination of tight junc-
tion electrical communication and paracrine influence, e.g.,
VEGF (62). Indeed, there was a significant reduction in peri-
cyte coverage of ECs during early phases of angiogenesis in
skeletal muscles of rats subjected to chronic electrical stimu-
lation, which suggested an antiangiogenic impact of pericytes
in this experimental model (33). In contrast, long-term periph-
eral vasodilation (prazosin model) or prolonged stretch (extir-
pation model) was accompanied by no change or an increase in
pericytes coverage, respectively (35). Thus the role of pericytes
in controlling physiological angiogenesis seems context depen-
dent, reflecting the nature of the initial stimulus (35), although
the contribution of pericytes subtypes to different angiotypes
has yet to be characterized (12).
Fibroblasts, mast cells, macrophages, and circulating cells.
Mesenchymal fibroblasts are cells within the interstitium that
synthesize the ECM and connective tissue of the stroma. They
are perhaps best known as the origin of pathological conditions
such as fibrosis but also aid inflammation and tumor growth.
Their physiological role is to support cell-cell interaction and
cell migration and may mediate angiogenesis chemically (via
expression of angiogenic factors) and mechanically (via dis-
ruption of connective tissue and ECM deposition) (67). In
sprouting angiogenesis, the number of fibroblasts increases
in close proximity to sites of neovascularization following
increased muscle activity and are responsible for much of the
mitotic activity evident with light microscopy (36), although
whether activated EC attract motile fibroblasts or activated
fibroblasts stimulate an EC response remains unclear (32).
Mast cells of the hematopoietic lineage are terminally dif-
ferentiated in peripheral tissue, where activation causes release
of growth factors and inflammatory cytokines that may stim-
ulate angiogenesis in a pathological environment such as found
in tumors. In muscle they are found within the interstitial, often
close to capillaries, where they are thought to be responsive to
both mechanical deformation and/or metabolite release. Al-
though mast cells may be important in cardiac muscle remod-
eling, their activation appears not to be an important regulator
of angiogenesis as a result of increased skeletal muscle activity
(28).
Similarly, macrophages are ubiquitous constituents of tissue
but are also thought to mainly play a role in inflammation-
mediated angiogenesis, as a result of secreted factors under
pathological conditions. However, the resident population may
be renewed by turnover or by infiltration of other macrophages.
Interestingly, an increase in these VEGF-positive cells within
the interstitium appears to be an early sign of angiogenesis in
response to increased muscle activity (18), perhaps an indica-
tion that part of the exercise-induced remodeling has an in-
flammatory basis (107).
There is increasing interest in the potential role of circulating
cells within the local vasculature for regulation of angiogene-
sis. Perhaps the best known are the hematopoietic stem cells
that support vigorous angiogenesis within solid tumors and
may supplement endothelial turnover during tissue repair.
Other cell types will require further investigation. However,
increased leukocyte concentration around venules (the sup-
posed site of new capillary growth) within skeletal muscle
suggest they may have some regulatory influence, but in
physiological angiogenesis this appears to be unlikely (105).
Intriguingly, however, circulating platelets appear to have a
differential effect on physiological angiogenesis within skeletal
muscle, likely influencing endothelial migration by cyclooxy-
genase signaling (105). Platelets are also a major site for the
production of TSP-1, which exerts a negative influence on EC
production and migration (19), but thus far there is little
evidence that circulating plasma/serum TSP-1 levels have any
direct influence on skeletal muscle angiogenesis.
Molecular Changes
The orchestration of molecular information at various levels
is required to generate the appropriate extent of angiogenesis in
skeletal muscles. Although details are still to be finalized, it is
evident that this involves sensitive feedback control and dis-
ruption of such signaling is likely a component of hyperpro-
liferative or ischemic vascular diseases. There is an ever-
growing list of pro- and antiangiogenic factors that must
remain in balance to effect microvascular homeostasis [see
reviews (53, 101)]. We will focus on the description of those
that have emerged as the major players and some new factors
(Table 1) that may provide significant impact on our under-
standing of physiologically controlled angiogenesis. This does
not diminish the potential importance of the factors not dis-
cussed here but points out that our current understanding for
many of the positive and negative angiogenic regulators re-
mains circumstantial and in some cases context dependent.
Vascular endothelial growth factor. VEGF exists in sev-
eral homodimeric isoforms: VEGF121, VEGF145, VEGF165,
VEGF189, and VEGF206 (85). Although several of these iso-
forms likely play a role in angiogenesis, VEGF165 has been
found to be the most central proangiogenic factor in skeletal
Table 1. Emerging regulators and their actions and
responses
Emerging Regulators Action/Response References
FoxO1 Modulate TSP-1 effects (94, 112, 118)
Nucleolin Interacts wiht VEGF and
MMP9.
(37, 64)
EC surface receptor for
endostatin.
(97, 98, 117)
Ephrin B2 Increased by stretch and
hypoxic stress.
(75, 128)
Polymerae -interacting
protein 2 (Poldip2)
Necessary for vascular
integerity, EC
proliferation, inhibition
of MMPs, and cell
adhesion.
(120)
PGC-1 and Secreted
phosphoprotein 1
Transcriptional coactivator
responsible in the
function of
mitochondrial biology,
electron transport chain,
 oxidation, and
influence on
angioregulatory
mitogens (e.g., VEGF).
(4, 96, 112)
Vasoinhibin-1 Anti-angiogenic mitogen (76, 78, 101)
Promotes vessel
stablization and
maturation.
Endosialin (CD248) Required for PDGFR	-
dependent capillary
sprouting angiogenesis.
(95)
FoxO1, Forkhead Box O 1; TSP-1, thrombospondin-1; MMP, matrix met-
alloproteinase; EC, endothelial cell; PDGFR, PDGF receptor.
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muscle. Some of the early evidence for the importance of
VEGF in angiogenesis was that the training-induced increase
in capillary growth was partially reduced with VEGF receptor
blockade (86). Moreover, treatment of rodents with a VEGF
sequestor revealed that VEGF is required for both shear stress-
and overload-induced angiogenesis (124). Studies on geneti-
cally modified mice lacking muscle-specific VEGF have dem-
onstrated that basal capillarization is markedly reduced com-
pared with wild-type mice (103) and that the training-induced
increases in capillary growth is abolished (26, 104), providing
solid evidence for the importance of VEGF in muscle. Addi-
tional studies using myocyte-specific, VEGF-deficient mice
revealed that skeletal muscle angiogenesis does not occur in
response to prazosin-mediated shear stress (122) or extirpation-
mediated muscle stretch (i.e., muscle overload) (45), which
seems to clearly establish that muscle fiber-derived VEGF is
essential to initiate the angiogenic process within skeletal
muscle.
An acute exercise bout leads to a transient, severalfold
increase in expression of VEGF mRNA (16, 48, 108) with
levels returning to baseline after 4–6 h of recovery (46, 73).
Levels of VEGF protein also increase after an acute exercise
bout in rodents (99) and are elevated during the first few weeks
of aerobic exercise training in young healthy individuals (47)
and animals (99), whereas in humans VEGF protein levels
appear to return to baseline after 4 wk of training (60). This
pattern of VEGF protein changes appears to be different in
individuals with lifestyle-related diseases (52) and ageing (22,
44), where muscle VEGF levels are lower in elderly than in
young individuals at baseline but are enhanced with exercise
training.
For muscle fiber-derived VEGF to promote angiogenesis,
secretion to the extracellular space is required, and mechanical
stimulus induced by passive movement of the muscle (56) or
active muscle contraction (39, 58) leads to increased muscle
interstitium VEGF levels. While increases in extracellular
VEGF can originate from different cell types including ECs,
fibroblast, and pericytes, evidence (noted above) points to
myocytes being the most important source (62, 73). Muscle
fibers contain high levels of VEGF stored in vesicles (62), and
synthesis of VEGF does not appear to be required for secretion
but likely occurs after contraction to replenish muscle stores
(62). The exercise-induced increase in muscle interstitial
VEGF does not appear to be altered by exercise training in
healthy individuals (39, 60) but may be improved by training in
individuals with lifestyle-related disease (52). At present, the
mechanisms underlying VEGF secretion from skeletal muscle,
and how this is altered by disease and exercise, has yet to be
fully determined. While there is robust evidence that VEGF is
required for the angiogenesis process, it must be emphasized
that VEGF cannot act alone, and other factors are also essential
and need to be co-regulated to elicit angiogenesis.
Nitric oxide. The gaseous, radical NO (NO· NO) is gen-
erated by the catalytic activity of three intracellular NO syn-
thases (NOSs). While the existence of the inducible NOS
(iNOS) in skeletal muscle is not confirmed, eNOS is found in
ECs of all vascular segments including capillaries (115),
whereas neuronal NOS (nNOS) is present at high concentra-
tions in the sarcolemma of skeletal muscle fibers in close
proximity to the microcirculation (119).
A modulatory impact of NO on angiogenesis has been
shown in rodents. Administration of NOS inhibitors, such as
NG-nitro-L-arginine (L-NNA) and N
-nitro-L-arginine methyl
ester (L-NAME), blunts angiogenesis in skeletal muscle in
response to chronic electrical stimulation (35) and whole body
exercise (40). Furthermore, the increased expression of
VEGFR-2 and VEGF proteins in skeletal muscles was abro-
gated in rats electrically stimulated for 2 and 4 days but not for
7 days (93). These data implied that chronic electrical stimu-
lation leads to induction of two peaks of VEGF and VEGFR-2
expression: an early first NO-dependent increase required for
the onset of angiogenesis and a later, NO-independent rise that
may aid maintenance of the expanding capillary bed (93).
However, chemical NOS inhibitors used do not typically
discriminate between NOS isoforms, and understanding the
differential impact of each one on angiogenic events requires
studies with NOS-deficient knockout (KO) mice. The VEGF
increase in ECs (23) and angiogenesis (8, 123) were blunted in
skeletal muscles of eNOS-KO mice after prazosin administra-
tion, suggesting that eNOS-derived NO produced represents an
obligate upstream signal for shear stress-induced angiogenesis
(8). This angiotype depends on functional hyperemia and the
vasodilatory potential of arteries, which is significantly lower
in eNOS-KO than WT mice (81, 129). In contrast, overload-
induced sprouting was not prevented in eNOS-KO mice, and
there was no effect on either splitting or sprouting angiogenesis
in nNOS-KO mice (10, 123). Hence, the influence of NO on
expression of VEGF might depend on the site of NO at which
it is generated and the context of the physical stimuli (29).
In humans, a direct role of NO for skeletal muscle angio-
genesis has not been determined; however, eNOS is upregu-
lated in muscle in response to acute exercise, exercise training,
and passive movement leading to increased shear stress (21,
54, 56). A similar role for eNOS and NO in angiogenesis in
humans, as seen in rodents, therefore seems likely.
Thrombospondin-1. The first reports that acute exercise
increased, but that exercise training decreased, skeletal muscle
TSP-1 expression (102) and that increasing shear stress de-
creased EC expression of TSP-1 (14) provided an incentive to
understand the role of negative regulators of angiogenesis in
this context (53, 101). Indeed, whereas a single exercise bout
increased skeletal muscle TSP-1 and VEGF mRNA expression
up to fourfold, repeated daily bouts of exercise reduces the
TSP-1 (but not VEGF) response to exercise (102). More
recently, the transcription factor Forkhead Box O 1 (FoxO1)
has been shown to transcriptionally regulate EC production of
TSP-1 (112). Whereas increasing FoxO1 can restrain angio-
genesis in ischemic skeletal muscle (94, 112), gene deletion of
FoxO1/FoxO3a abolished the increase in TSP-1 expression
following acute exercise and induced a more rapid exercise-
induced expansion in muscle capillarity (118). Studies exam-
ining skeletal muscle expression of TSP-1 in response to
varying duration and intensity of exercise training (60, 68, 69,
82, 88, 89) indicate that it likely plays a key regulatory role in
controlling the onset of exercise-induced angiogenesis. Thus,
while VEGF-A is perhaps the most central angiogenic mitogen
whose secretion is an absolute requirement for the initiation of
skeletal muscle angiogenesis, it appears that TSP-1 may be
essential for the necessary physiological constraint on capillary
expansion (100).
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Responses following physical deconditioning (i.e., de-
training) in rodents demonstrate that capillary regression
seems to occur in temporal correlation to muscle TSP-1
protein expression, even in the face of elevated muscle
VEGF expression (97). Hence, while VEGF is necessary to
initiate angiogenesis, it appears that TSP-1 (and likely other
antiangiogenic factors) may exert principal control on the
growth process, determining when and possibly where an-
giogenesis takes place. Indeed, there is also ample evidence
from gain and loss of function studies involving TSP-1 that
support the importance of TSP-1 in regulating muscle an-
giogenesis under both physiological (6, 89) and pathological
(70, 80, 92) conditions.
Other pro- and antiangiogenic factors. While much atten-
tion has focused on VEGF-A, and increasingly TSP-1, numer-
ous other factors are known to exhibit either proangiogenic or
anti-angiogenic properties in other tissue. These include
growth factor/cognate receptor pairings such as the angiopoi-
etins/TIE receptors, ephrins/Ephs, FGFs/FGF receptors,
PDGFs/PDGF receptors, and delta-like ligand 4/notch, in ad-
dition to endothelial function modulators such as nNOS and
eNOS. There is a growing realization that these factors need to
be presented in spatially and temporally balanced sequences
for the formation and maintenance of functional vessels in
skeletal muscle [reviewed in Olfert and Birot (101)]. Further-
more, various proteins without previously established function
in vascular biology, such as secretion of phosphoprotein 1
(113), polymerase -interacting protein 2 (2), nucleolin (97,
98), as well as peroxisome proliferator-activated receptor-
coactivator 1 (PGC-1), all appear to have influence on
capillarity in skeletal muscles.
Notably, PGC-1 is a key transcriptional coactivator that
regulates expression of genes involved in mitochondrial bio-
genesis and energy metabolism (50, 99). Recent evidence from
muscle-specific PGC-1 KO mice suggest that this factor is an
important mediator of exercise-induced angiogenesis (4). The
molecular mechanisms behind this effect include exercise-
dependent 	-adrenergic signaling that induces transcription of
an additional isoform (PGC-12) from an alternative promoter,
which in turn increased expression of angiogenic factors such
as VEGF-A and angiopoietin 2 (4, 20, 84). The use of this
alternative PGC-1 promotor also seems important for the
response of skeletal muscle to exercise in humans (96). An-
giogenic activity of PGC-1 might involve its downstream
ligand peroxisome proliferator-activated receptor-	/ (13).
Translation of PGC-12 mRNA leads to two PGC-1 protein
variants with slightly different NH2-terminus (PGC-12 and
PGC-13) (20). A recent study suggests that PGC-12 is the
most responsive to a single exercise bout in human skeletal
muscle (42). Despite remaining questions, it is clear that
PGC-1 and its isoforms likely play an important role in
regulating skeletal muscle angiogenesis.
Notwithstanding that the expanding list of factors that are
now known to have an impact on this physiological process,
their roles often remain only partially understood and need to
be characterized in more detail. A vital and important arena for
future research is the specific roles and particularly the inter-
play of these gene products during angiogenesis in skeletal
muscle.
Summary and Relevance
Beyond growth and development, physiologically controlled
angiogenesis is largely limited to 1) the female reproductive
cycle, i.e., menses, involving smooth muscle, and 2) skeletal
muscle adaptation to exercise stimuli. Therefore, studies aimed
at understanding angioadaptation and regulation of angiogen-
esis in muscle provide a great opportunity to investigate and
understand the complexity and highly structured choreography
essential for controlled regulation of angiogenesis. Given the
number of diseases that involve aberrant regulation of angio-
genesis, resulting in either uncontrolled vessel growth or cap-
illary rarefaction, it is imperative that a fundamental under-
standing of the mechanisms that work to effectively control
angiogenesis is attained, before we can truly fully understand
pathological dysregulation. Indeed, lessons learnt from the past
decade reinforce the need for a more comprehensive under-
standing of the temporal control and degree of interaction
between stimulators and inhibitors of angiogenesis that goes
beyond single gene and protein responses. It is here that use of
multiplexing technology, including but not limited to -omic
levels approaches, will allow a more global assessment angio-
genic-related factors which provide the greatest opportunities
to fully understand the complex interplay between stimulators
and inhibitors of angiogenesis. From this foundation we will be
better equipped to develop tools and/or therapies that effec-
tively combat uncontrolled vessel growth (such as that seen in
cancer/tumor development) or capillary loss often associated
with many chronic diseases (such as diabetes, hypertension,
Alzheimer’s, osteoporosis, etc.).
GRANTS
I. M. Olfert received financial support, in part, by a grant to the West
Virginia Clinical and Translational Science Institute (National Institute of
General Medical Sciences Grant U54GM104942), American Heart Associa-
tion Innovation Research Grant 13IRG14330015, West Virginia University
Research Foundation PSCoR grant, and from West Virginia University School
of Medicine. O. Baum recieved financial support by Swiss National Science
Foundation Grant 320030-144167. Y. Hellsten recieved financial support from
The Danish Council for Independent Research-Medical Sciences, The Lund-
beck Foundation, Novo Nordisk Foundation, and the Danish Ministry of
Culture. S. Egginton recieved financial support from the British Heart Foun-
dation Grant PG/14/15/30691.
DISCLOSURES
No conflicts of interest, financial or otherwise, are declared by the author(s).
AUTHOR CONTRIBUTIONS
I.M.O., O.B., Y.H., and S.E. worked together on the conception, design,
interpretation and critical analysis of the data and literature reviewed; I.M.O.
and O.B. prepared figures; and all authors participated in drafting the manu-
script and approving the final version of manuscript.
REFERENCES
1. Adair TH. Growth regulation of the vascular system: an emerging role
for adenosine. Am J Physiol Regul Integr Comp Physiol 289: R283–
R296, 2005.
2. Amanso AM, Lassegue B, Joseph G, Landazuri N, Long JS, Weiss D,
Taylor WR, Griendling KK. Polymerase delta-interacting protein 2
promotes postischemic neovascularization of the mouse hindlimb. Arte-
rioscler Thromb Vasc Biol 34: 1548–1555, 2014.
3. Andersen P, Saltin B. Maximal perfusion of skeletal muscle in man. J
Physiol 366: 233–249, 1985.
4. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G,
Cooper M, Laznik D, Chinsomboon J, Rangwala SM, Baek KH,
Rosenzweig A, Spiegelman BM. HIF-independent regulation of VEGF
Review
H333SKELETAL MUSCLE ANGIOGENESIS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00635.2015 • www.ajpheart.org
and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature
451: 1008–1012, 2008.
5. Ariano MA, Armstrong RB, Edgerton VR. Hindlimb muscle fiber
populations of five mammals. J Histochem Cytochem 21: 51–55, 1973.
6. Audet GN, Fulks D, Stricker JC, Olfert IM. Chronic delivery of a
thrombospondin-1 mimetic decreases skeletal muscle capillarity in mice.
PLoS One 8: e55953, 2013.
7. Basic VT, Jacobsen A, Sirsjo A, Abdel-Halim SM. TNF stimulation
induces VHL overexpression and impairs angiogenic potential in skeletal
muscle myocytes. Int J Mol Med 34: 228–236, 2014.
8. Baum O, Da Silva-Azevedo L, Willerding G, Wockel A, Planitzer G,
Gossrau R, Pries AR, Zakrzewicz A. Endothelial NOS is main medi-
ator for shear stress-dependent angiogenesis in skeletal muscle after
prazosin administration. Am J Physiol Heart Circ Physiol 287: H2300–
H2308, 2004.
9. Baum O, Gubeli J, Frese S, Torchetti E, Malik C, Odriozola A,
Graber F, Hoppeler HH, Tschanz SA. Angiogenesis-related ultrastruc-
tural changes of capillaries in human skeletal muscle in response to
endurance exercise. J Appl Physiol 119: 1118–1126, 2015.
10. Baum O, Vieregge M, Koch P, Gul S, Hahn S, Huber-Abel FA, Pries
AR, Hoppeler H. Phenotype of capillaries in skeletal muscle of nNOS-
knockout mice. Am J Physiol Regul Integr Comp Physiol 304: R1175–
R1182, 2013.
11. Benoit H, Jordan M, Wagner H, Wagner PD. Effect of NO, vasodi-
lator prostaglandins, and adenosine on skeletal muscle angiogenic growth
factor gene expression. J Appl Physiol 86: 1513–1518, 1999.
12. Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A,
Delbono O. Type-2 pericytes participate in normal and tumoral angio-
genesis. Am J Physiol Cell Physiol 307: C25–C38, 2014.
13. Bishop-Bailey D. PPARs and angiogenesis. Biochem Soc Trans 39:
1601–1605, 2011.
14. Bongrazio M, Da Silva-Azevedo L, Bergmann EC, Baum O, Hinz B,
Pries AR, Zakrzewicz A. Shear stress modulates the expression of
thrombospondin-1 and CD36 in endothelial cells in vitro and during
shear stress-induced angiogenesis in vivo. Int J Immunopathol Pharma-
col 19: 35–48, 2006.
15. Brasseur JE, Curtis RL, Mellender JW, Rimm AA, Melvin JL,
Sulaiman AR. Systematic distribution of muscle fiber types in the
medial gastrocnemius of the laboratory mouse: a morphometric analysis.
Anat Rec 218: 396–401, 1987.
16. Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, Wagner
PD. Angiogenic growth factor mRNA responses in muscle to a single
bout of exercise. J Appl Physiol 81: 355–361, 1996.
17. British Heart Foundation. Put your heart into walking: British Heart
Foundation, 2013.
18. Brown MD, Egginton S, Hudlická O, Milkiewicz M, Verhaeg J.
Macrophages as a source of VEGF in activity-induced angiogenesis in rat
skeletal muscle. XXXIVth IUPS Congress, Christchurch, New Zealand
(pre-circulated abstract), 2001.
19. Chen H, Herndon ME, Lawler J. The cell biology of thrombospon-
din-1. Matrix Biol 19: 597–614, 2000.
20. Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC,
Sawada N, Raghuram S, Arany Z. The transcriptional coactivator
PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle.
Proc Natl Acad Sci USA 106: 21401–21406, 2009.
21. Cocks M, Shaw CS, Shepherd SO, Fisher JP, Ranasinghe AM,
Barker TA, Tipton KD, Wagenmakers AJ. Sprint interval and endur-
ance training are equally effective in increasing muscle microvascular
density and eNOS content in sedentary males. J Physiol 591: 641–656,
2013.
22. Croley AN, Zwetsloot KA, Westerkamp LM, Ryan NA, Pendergast
AM, Hickner RC, Pofahl WE, Gavin TP. Lower capillarization, VEGF
protein, and VEGF mRNA response to acute exercise in the vastus
lateralis muscle of aged vs. young women. J Appl Physiol 99: 1872–
1879, 2005.
23. Da Silva-Azevedo L, Baum O, Zakrzewicz A, Pries AR. Vascular
endothelial growth factor is expressed in endothelial cells isolated from
skeletal muscles of nitric oxide synthase knockout mice during prazosin-
induced angiogenesis. Biochem Biophys Res Commun 297: 1270–1276,
2002.
24. Dawson JM, Hudlicka O. The effects of long term administration of
prazosin on the microcirculation in skeletal muscles. Cardiovasc Res 23:
913–920, 1989.
25. Degens H, Turek Z, Hoofd LJ, Van’t Hof MA, Binkhorst RA. The
relationship between capillarisation and fibre types during compensatory
hypertrophy of the plantaris muscle in the rat. J Anat 180: 455–463,
1992.
26. Delavar H, Nogueira L, Wagner PD, Hogan MC, Metzger D, Breen
EC. Skeletal myofiber VEGF is essential for the exercise training
response in adult mice. Am J Physiol Regul Integr Comp Physiol 306:
R586–R595, 2014.
27. Delp MD, Duan C. Composition and size of type I, IIA, IID/X, and IIB
fibers and citrate synthase activity of rat muscle. J Appl Physiol 80:
261–270, 1996.
28. Doyle JL, Haas TL. The angiogenic response to skeletal muscle over-
load is not dependent on mast cell activation. Microcirculation 17:
548–556, 2010.
29. Egginton S. Invited review: activity-induced angiogenesis. Pflügers
Arch 457: 963–977, 2009.
30. Egginton S. Morphometric analysis of tissue capillary supply. In: Ad-
vances in Comparative and Environmental Physiology: Vertebrate Gas
Exchange. Berlin: Springer-Verlag, 1990, p. 73–141.
31. Egginton S. Numerical and areal density estimates of fibre type compo-
sition in a skeletal muscle (rat extensor digitorum longus). J Anat 168:
73–80, 1990.
32. Egginton S. Physiological factors influencing capillary growth. Acta
Physiol (Oxf) 202: 225–239, 2011.
33. Egginton S, Hudlicka O, Brown MD, Graciotti L, Granata AL. In
vivo pericyte-endothelial cell interaction during angiogenesis in adult
cardiac and skeletal muscle. Microvasc Res 51: 213–228, 1996.
34. Egginton S, Turek Z. Comparative distributions of numerical and areal
indices of tissue capillarity. Adv Exp Med Biol 277: 161–169, 1990.
35. Egginton S, Zhou AL, Brown MD, Hudlicka O. The role of pericytes
in controlling angiogenesis in vivo. Adv Exp Med Biol 476: 81–99, 2000.
36. Egginton S, Zhou AL, Brown MD, Hudlicka O. Unorthodox angio-
genesis in skeletal muscle. Cardiovasc Res 49: 634–646, 2001.
37. Fahling M, Steege A, Perlewitz A, Nafz B, Mrowka R, Persson PB,
Thiele BJ. Role of nucleolin in posttranscriptional control of MMP-9
expression. Biochim Biophys Acta 1731: 32–40, 2005.
38. Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C,
Chaitman B, Epstein S, Froelicher ES, Froelicher VF, Pina IL,
Pollock ML. Statement on exercise: benefits and recommendations for
physical activity programs for all Americans. A statement for health
professionals by the Committee on Exercise and Cardiac Rehabilitation
of the Council on Clinical Cardiology, American Heart Association.
Circulation 94: 857–862, 1996.
39. Gavin TP, Ruster RS, Carrithers JA, Zwetsloot KA, Kraus RM,
Evans CA, Knapp DJ, Drew JL, McCartney JS, Garry JP, Hickner
RC. No difference in the skeletal muscle angiogenic response to aerobic
exercise training between young and aged men. J Physiol 585: 231–239,
2007.
40. Gavin TP, Spector DA, Wagner H, Breen EC, Wagner PD. Nitric
oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA
response to exercise. J Appl Physiol 88: 1192–1198, 2000.
41. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogen-
esis. Cell Tissue Res 314: 15–23, 2003.
42. Gidlund Ek Ydfors M, Appel S, Rundqvist H, Sundberg CJ,
Norrbom JM. Rapidly elevated levels of PGC-1-b protein in human
skeletal muscle after exercise: exploring regulatory factors in a random-
ized controlled trial. J Appl Physiol 119: 374–384, 2015.
43. Gliemann L, Gunnarsson TP, Hellsten Y, Bangsbo J. 10-20-30 train-
ing increases performance and lowers blood pressure and VEGF in
runners. Scand J Med Sci Sports 25: e479–e489, 2015.
44. Gliemann L, Olesen J, Bienso RS, Schmidt JF, Akerstrom T, Nyberg
M, Lindqvist A, Bangsbo J, Hellsten Y. Resveratrol modulates the
angiogenic response to exercise training in skeletal muscles of aged men.
Am J Physiol Heart Circ Physiol 307: H1111–H1119, 2014.
45. Gorman JL, Liu ST, Slopack D, Shariati K, Hasanee A, Olenich S,
Olfert IM, Haas TL. Angiotensin II evokes angiogenic signals within
skeletal muscle through co-ordinated effects on skeletal myocytes and
endothelial cells. PLoS One 9: e85537, 2014.
46. Gustafsson T, Ameln H, Fischer H, Sundberg CJ, Timmons JA,
Jansson E. VEGF-A splice variants and related receptor expression in
human skeletal muscle following submaximal exercise. J Appl Physiol
98: 2137–2146, 2005.
47. Gustafsson T, Knutsson A, Puntschart A, Kaijser L, Nordqvist AC,
Sundberg CJ, Jansson E. Increased expression of vascular endothelial
Review
H334 SKELETAL MUSCLE ANGIOGENESIS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00635.2015 • www.ajpheart.org
growth factor in human skeletal muscle in response to short-term one-
legged exercise training. Pflügers Arch 444: 752–759, 2002.
48. Gustafsson T, Sundberg CJ. Expression of angiogenic growth factors in
hum,an skeletal muscle in response to a singular bout of exercise. Am J
Physiol Heart Circ Physiol 279: H3144–H3145, 2000.
49. Haas TL, Milkiewicz M, Davis SJ, Zhou AL, Egginton S, Brown MD,
Madri JA, Hudlicka O. Matrix metalloproteinase activity is required for
activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart
Circ Physiol 279: H1540–H1547, 2000.
50. Handschin C, Spiegelman BM. Peroxisome proliferator-activated re-
ceptor gamma coactivator 1 coactivators, energy homeostasis, and me-
tabolism. Endocr Rev 27: 728–735, 2006.
51. Hansen-Smith FM, Hudlicka O, Egginton S. In vivo angiogenesis in
adult rat skeletal muscle: early changes in capillary network architecture
and ultrastructure. Cell Tissue Res 286: 123–136, 1996.
52. Hansen AH, Nielsen JJ, Saltin B, Hellsten Y. Exercise training nor-
malizes skeletal muscle vascular endothelial growth factor levels in
patients with essential hypertension. J Hypertens 28: 1176–1185, 2010.
53. Hellsten Y, Hoier B. Capillary growth in human skeletal muscle:
physiological factors and the balance between pro-angiogenic and angio-
static factors. Biochem Soc Trans 42: 1616–1622, 2014.
54. Hellsten Y, Nielsen JJ, Lykkesfeldt J, Bruhn M, Silveira L, Pilegaard
H, Bangsbo J. Antioxidant supplementation enhances the exercise-
induced increase in mitochondrial uncoupling protein 3 and endothelial
nitric oxide synthase mRNA content in human skeletal muscle. Free
Radic Biol Med 43: 353–361, 2007.
55. Hellsten Y, Nyberg M, Jensen LG, Mortensen SP. Vasodilator inter-
actions in skeletal muscle blood flow regulation. J Physiol 590: 6297–
6305, 2012.
56. Hellsten Y, Rufener N, Nielsen JJ, Hoier B, Krustrup P, Bangsbo J.
Passive leg movement enhances interstitial VEGF protein, endothelial
cell proliferation, and eNOS mRNA content in human skeletal muscle.
Am J Physiol Regul Integr Comp Physiol 294: R975–R982, 2008.
57. Hirschi KK, D’Amore PA. Control of angiogenesis by the pericyte:
molecular mechanisms and significance. EXS 79: 419–428, 1997.
58. Hoffner L, Nielsen JJ, Langberg H, Hellsten Y. Exercise but not
prostanoids enhance levels of vascular endothelial growth factor and
other proliferative agents in human skeletal muscle interstitium. J Physiol
550: 217–225, 2003.
59. Hoier B, Hellsten Y. Exercise-induced capillary growth in human
skeletal muscle and the dynamics of VEGF. Microcirculation 21: 301–
314, 2014.
60. Hoier B, Nordsborg N, Andersen S, Jensen L, Nybo L, Bangsbo J,
Hellsten Y. Pro- and anti-angiogenic factors in human skeletal muscle in
response to acute exercise and training. J Physiol 590: 595–606, 2012.
61. Hoier B, Passos M, Bangsbo J, Hellsten Y. Intense intermittent exercise
provides weak stimulus for vascular endothelial growth factor secretion
and capillary growth in skeletal muscle. Exp Physiol 98: 585–597, 2013.
62. Hoier B, Prats C, Qvortrup K, Pilegaard H, Bangsbo J, Hellsten Y.
Subcellular localization and mechanism of secretion of vascular endo-
thelial growth factor in human skeletal muscle. FASEB J 27: 3496–3504,
2013.
63. Hoppeler H, Kayar S. Capillarity and oxidative capacity of muscles.
Physiology 3: 113–116, 1988.
64. Huang Y, Shi H, Zhou H, Song X, Yuan S, Luo Y. The angiogenic
function of nucleolin is mediated by vascular endothelial growth factor
and nonmuscle myosin. Blood 107: 3564–3571, 2006.
65. Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and
cardiac muscle. Physiol Rev 72: 369–417, 1992.
66. Hudlicka O, Brown M, Egginton S. The microcirculation in skeletal
muscle. In: Myology, Basic and Clinical (3rd ed.), edited by Engel A and
Franzini-Armstrong C. New York: McGraw-Hill, 2004, p. 511–533.
67. Hurley JR, Balaji S, Narmoneva DA. Complex temporal regulation of
capillary morphogenesis by fibroblasts. Am J Physiol Cell Physiol 299:
C444–C453, 2010.
68. Huttemann M, Lee I, Malek MH. ()-Epicatechin maintains endur-
ance training adaptation in mice after 14 days of detraining. FASEB J 26:
1413–1422, 2012.
69. Huttemann M, Lee I, Perkins GA, Britton SL, Koch LG, Malek MH.
()-Epicatechin is associated with increased angiogenic and mitochon-
drial signalling in the hindlimb of rats selectively bred for innate low
running capacity. Clin Sci (Lond) 124: 663–674, 2013.
70. Isenberg JS, Qin Y, Maxhimer JB, Sipes JM, Despres D, Schner-
mann J, Frazier WA, Roberts DD. Thrombospondin-1 and CD47
regulate blood pressure and cardiac responses to vasoactive stress. Matrix
Biol 28: 110–119, 2009.
71. Isenberg JS, Ridnour LA, Perruccio EM, Espey MG, Wink DA,
Roberts DD. Thrombospondin-1 inhibits endothelial cell responses to
nitric oxide in a cGMP-dependent manner. Proc Natl Acad Sci USA 102:
13141–13146, 2005.
72. Jensen L, Bangsbo J, Hellsten Y. Effect of high intensity training on
capillarization and presence of angiogenic factors in human skeletal
muscle. J Physiol 557: 571–582, 2004.
73. Jensen L, Schjerling P, Hellsten Y. Regulation of VEGF and bFGF
mRNA expression and other proliferative compounds in skeletal muscle
cells. Angiogenesis 7: 255–267, 2004.
74. Jobin J, Maltais F, Doyon JF, LeBlanc P, Simard PM, Simard AA,
Simard C. Chronic obstructive pulmonary disease: capillarity and fiber-
type characteristics of skeletal muscle. J Cardiopulm Rehabil 18: 432–
437, 1998.
75. Katsu M, Koyama H, Maekawa H, Kurihara H, Uchida H, Hamada
H. Ex vivo gene delivery of ephrin-B2 induces development of func-
tional collateral vessels in a rabbit model of hind limb ischemia. J Vasc
Surg 49: 192–198, 2009.
76. Kerbel RS. Vasohibin: the feedback on a new inhibitor of angiogenesis.
J Clin Invest 114: 884–886, 2004.
77. Kikuchi R, Nakamura K, MacLauchlan S, Ngo DTM, Shimizu I,
Fuster JJ, Katanasaka Y, Yoshida S, Qiu Y, Yamaguchi TP, Mat-
sushita T, Murohara T, Gokce N, Bates DO, Hamburg NM, Walsh
K. An antiangiogenic isoform of VEGF-A contributes to impaired
vascularization in peripheral artery disease. Nat Med 20: 1464–1471,
2014.
78. Kishlyansky M, Vojnovic J, Roudier E, Gineste C, Decary S, Forn P,
Bergeron R, Desplanches D, Birot O. Striated muscle angio-adaptation
requires changes in Vasohibin-1 expression pattern. Biochem Biophys
Res Commun 399: 359–364, 2010.
79. Kivela R, Silvennoinen M, Touvra AM, Lehti TM, Kainulainen H,
Vihko V. Effects of experimental type 1 diabetes and exercise training on
angiogenic gene expression and capillarization in skeletal muscle.
FASEB J 20: 1570–1572, 2006.
80. Kondo H, Fujino H, Murakami S, Tanaka M, Kanazashi M, Na-
gatomo F, Ishihara A, Roy RR. Low-intensity running exercise en-
hances the capillary volume and pro-angiogenic factors in the soleus
muscle of type 2 diabetic rats. Muscle Nerve 51: 391–399, 2015.
81. Lau KS, Grange RW, Isotani E, Sarelius IH, Kamm KE, Huang PL,
Stull JT. nNOS and eNOS modulate cGMP formation and vascular
response in contracting fast-twitch skeletal muscle. Physiol Genomics 2:
21–27, 2000.
82. Lee I, Hüttemann M, Kruger A, Bollig-Fischer A, Malek MH.
()-Epicatechin combined with 8 weeks of treadmill exercise is associ-
ated with increased angiogenic and mitochondrial signaling in mice.
Front Pharmacol 6: 43, 2015.
83. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S,
Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML. Autocrine VEGF
signaling is required for vascular homeostasis. Cell 130: 691–703, 2007.
84. Leick L, Hellsten Y, Fentz J, Lyngby SS, Wojtaszewski JF, Hidalgo
J, Pilegaard H. PGC-1alpha mediates exercise-induced skeletal muscle
VEGF expression in mice. Am J Physiol Endocrinol Metab 297: E92–
E103, 2009.
85. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N.
Vascular endothelial growth factor is a secreted angiogenic mitogen.
Science 246: 1306–1309, 1989.
86. Lloyd PG, Prior BM, Li H, Yang HT, Terjung RL. VEGF receptor
antagonism blocks arteriogenesis, but only partially inhibits angiogene-
sis, in skeletal muscle of exercise-trained rats. Am J Physiol Heart Circ
Physiol 288: H759–H768, 2005.
87. Lloyd PG, Yang HT, Terjung RL. Arteriogenesis and angiogenesis in
rat ischemic hindlimb: role of nitric oxide. Am J Physiol Heart Circ
Physiol 281: H2528–H2538, 2001.
88. Malek MH, Huttemann M, Lee I, Coburn JW. Similar skeletal muscle
angiogenic and mitochondrial signalling following 8 weeks of endurance
exercise in mice: discontinuous versus continuous training. Exp Physiol
98: 807–818, 2013.
89. Malek MH, Olfert IM. Global deletion of thrombospondin-1 increases
cardiac and skeletal muscle capillarity and exercise capacity in mice. Exp
Physiol 94: 749–760, 2009.
Review
H335SKELETAL MUSCLE ANGIOGENESIS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00635.2015 • www.ajpheart.org
90. Mathieu-Costello O, Hoppeler H, Weibel ER. Capillary tortuosity in
skeletal muscles of mammals depends on muscle contraction. J Appl
Physiol 66: 1436–1442, 1989.
91. Mathieu O, Cruz-Orive LM, Hoppeler H, Weibel ER. Estimating
length density and quantifying anisotropy in skeletal muscle capillaries.
J Microsc 131: 131–146, 1983.
92. Maxhimer JB, Shih HB, Isenberg JS, Miller TW, Roberts DD.
Thrombospondin-1/CD47 blockade following ischemia-reperfusion in-
jury is tissue protective. Plast Reconstr Surg 124: 1880–1889, 2009.
93. Milkiewicz M, Hudlicka O, Brown MD, Silgram H. Nitric oxide,
VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in
rat skeletal muscle. Am J Physiol Heart Circ Physiol 289: H336–H343,
2005.
94. Milkiewicz M, Roudier E, Doyle JL, Trifonova A, Birot O, Haas TL.
Identification of a mechanism underlying regulation of the anti-angio-
genic forkhead transcription factor FoxO1 in cultured endothelial cells
and ischemic muscle. Am J Pathol 178: 935–944, 2011.
95. Naylor AJ, McGettrick HM, Maynard WD, May P, Barone F, Croft
AP, Egginton S, Buckley CD. A differential role for CD248 (Endosia-
lin) in PDGF-mediated skeletal muscle angiogenesis. PLoS One 9:
e107146, 2014.
96. Norrbom J, Sallstedt EK, Fischer H, Sundberg CJ, Rundqvist H,
Gustafsson T. Alternative splice variant PGC-1alpha-b is strongly in-
duced by exercise in human skeletal muscle. Am J Physiol Endocrinol
Metab 301: E1092–E1098, 2011.
97. Olenich SA, Audet GN, Roberts KA, Olfert IM. Effects of detraining
on the temporal expression of positive and negative angioregulatory
proteins in skeletal muscle of mice. J Physiol 592: 3325–3338, 2014.
98. Olenich SA, Gutierrez-Reed N, Audet GN, Olfert IM. Temporal
response of positive and negative angiogenic regulators in response to
acute and chronic exercise training in mice. J Physiol 591: 5157–5169,
2013.
99. Olenich J, Kiilerich K, Pilegaard H. PGC-1alpha-mediated adaptations
in skeletal muscle. Pflügers Arch 460: 153–162, 2010.
100. Olesen IM. Physiological capillary regression is not dependent on
reducing VEGF expression. Microcirculation. 2015 Dec 11. doi:10.1111/
micc.12263. [Epub ahead of print].
101. Olfert IM, Birot O. Importance of anti-angiogenic factors in the regu-
lation of skeletal muscle angiogenesis. Microcirculation 18: 316–330,
2011.
102. Olfert IM, Breen EC, Gavin TP, Wagner PD. Temporal thrombos-
pondin-1 mRNA response in skeletal msucle exposed to acute and
chronic exercise. Growth Factors 24: 253–259, 2006.
103. Olfert IM, Howlett RA, Tang K, Dalton ND, Gu Y, Peterson KL,
Wagner PD, Breen EC. Muscle-specific VEGF deficiency greatly re-
duces exercise endurance in mice. J Physiol 587: 1755–1767, 2009.
104. Olfert IM, Howlett RA, Wagner PD, Breen EC. Myocyte vascular
endothelial growth factor is required for exercise-induced skeletal muscle
angiogenesis. Am J Physiol Regul Integr Comp Physiol 299: R1059–
R1067, 2010.
105. Packham IM, Watson SP, Bicknell R, Egginton S. In vivo evidence for
platelet-induced physiological angiogenesis by a COX driven mecha-
nism. PLoS One 9: e107503, 2014.
106. Pearce SC, Hudlicka O, Brown MD. Effect of indomethacin on
capillary growth and microvasculature in chronically stimulated rat
skeletal muscles. J Physiol 526: 435–443, 2000.
107. Pedersen BK. Muscle as a secretory organ. Compr Physiol 3: 1337–
1362, 2013.
108. Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA,
Wagner PD. Human VEGF gene expression in skeletal muscle: effect of
acute normoxic and hypoxic exercise. Am J Physiol Heart Circ Physiol
277: H2247–H2252, 1999.
109. Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD,
Wink DA. Nitric oxide regulates angiogenesis through a functional
switch involving thrombospondin-1. Proc Natl Acad Sci USA 102:
13147–13152, 2005.
110. Rivilis I, Milkiewicz M, Boyd P, Goldstein J, Brown MD, Egginton S,
Hansen FM, Hudlicka O, Haas TL. Differential involvement of
MMP-2 and VEGF during muscle stretch- versus shear stress-induced
angiogenesis. Am J Physiol Heart Circ Physiol 283: H1430–H1438,
2002.
111. Rosenblatt JD, Kuzon WM Jr, Plyley MJ, Pynn BR, McKee NH. A
histochemical method for the simultaneous demonstration of capillaries
and fiber type in skeletal muscle. Stain Technol 62: 85–92, 1987.
112. Roudier E, Milkiewicz M, Birot O, Slopack D, Montelius A, Gustafs-
son T, Paik JH, DePinho RA, Casale GP, Pipinos II, Haas TL.
Endothelial FoxO1 is an intrinsic regulator of thrombospondin 1 expres-
sion that restrains angiogenesis in ischemic muscle. Angiogenesis 16:
759–772, 2013.
113. Rowe GC, Raghuram S, Jang C, Nagy JA, Patten IS, Goyal A, Chan
MC, Liu LX, Jiang A, Spokes KC, Beeler D, Dvorak H, Aird WC,
Arany Z. PGC-1alpha induces SPP1 to activate macrophages and or-
chestrate functional angiogenesis in skeletal muscle. Circ Res 115:
504–517, 2014.
114. Sarelius I, Pohl U. Control of muscle blood flow during exercise: local
factors and integrative mechanisms. Acta Physiol (Oxf) 199: 349–365,
2010.
115. Segal SS, Brett SE, Sessa WC. Codistribution of NOS and caveolin
throughout peripheral vasculature and skeletal muscle of hamsters. Am J
Physiol Heart Circ Physiol 277: H1167–H1177, 1999.
116. Sher J, Cardasis C. Skeletal muscle fiber types in the adult mouse. Acta
Neurol Scand 54: 45–56, 1976.
117. Shi H, Huang Y, Zhou H, Song X, Yuan S, Fu Y, Luo Y. Nucleolin is
a receptor that mediates antiangiogenic and antitumor activity of endosta-
tin. Blood 110: 2899–2906, 2007.
118. Slopack D, Roudier E, Liu ST, Nwadozi E, Birot O, Haas TL.
Forkhead BoxO transcription factors restrain exercise-induced angiogen-
esis. J Physiol 592: 4069–4082, 2014.
119. Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle.
Physiol Rev 81: 209–237, 2001.
120. Sutliff RL, Hilenski LL, Amanso AM, Parastatidis I, Dikalova AE,
Hansen L, Datla SR, Long JS, El-Ali AM, Joseph G, Gleason RL,
Taylor WR, Hart CM, Griendling KK, Lassègue B. Polymerase delta
interacting protein 2 sustains vascular structure and function. Arterioscler
Thromb Vasc Biol 33: 2154–2161, 2013.
121. Tomanek RJ, Torry RJ. Growth of the coronary vasculature in hyper-
trophy: mechanisms and model dependence. Cell Mol Biol Res 40:
129–136, 1994.
122. Uchida C, Nwadozi E, Hasanee A, Olenich S, Olfert IM, Haas TL.
Muscle-derived vascular endothelial growth factor regulates microvas-
cular remodelling in response to increased shear stress in mice. Acta
Physiol (Oxf) 214: 349–360, 2015.
123. Williams JL, Cartland D, Hussain A, Egginton S. A differential role
for nitric oxide in two forms of physiological angiogenesis in mouse. J
Physiol 570: 445–454, 2006.
124. Williams JL, Cartland D, Rudge JS, Egginton S. VEGF trap abolishes
shear stress- and overload-dependent angiogenesis in skeletal muscle.
Microcirculation 13: 499–509, 2006.
125. Williamson JR, Hoffmann PL, Kohrt WM, Spina RJ, Coggan AR,
Holloszy O. Endurance exercise training decreases capillary basement
membrane width in older nondiabetic and diabetic adults. J Appl Physiol
80: 747–753, 1996.
126. World Health Organization. Global recommendations on physical
activity for health. Geneva: World Health Organization, 2010.
127. Wragg JW, Durant S, McGettrick HM, Sample KM, Egginton S,
Bicknell R. Shear stress regulated gene expression and angiogenesis in
vascular endothelium. Microcirculation 21: 290–300, 2014.
128. Yamashita T, Ohneda K, Nagano M, Miyoshi C, Kaneko N, Miwa Y,
Yamamoto M, Ohneda O, Fujii-Kuriyama Y. Hypoxia-inducible tran-
scription factor-2alpha in endothelial cells regulates tumor neovascular-
ization through activation of ephrin A1. J Biol Chem 283: 18926–18936,
2008.
129. Yu J, deMuinck ED, Zhuang Z, Drinane M, Kauser K, Rubanyi GM,
Qian HS, Murata T, Escalante B, Sessa WC. Endothelial nitric oxide
synthase is critical for ischemic remodeling, mural cell recruitment, and
blood flow reserve. Proc Natl Acad Sci USA 102: 10999–11004, 2005.
130. Zhou A, Egginton S, Hudlicka O, Brown MD. Internal division of
capillaries in rat skeletal muscle in response to chronic vasodilator
treatment with alpha1-antagonist prazosin. Cell Tissue Res 293: 293–
303, 1998.
131. Zhou AL, Egginton S, Brown MD, Hudlicka O. Capillary growth in
overloaded, hypertrophic adult rat skeletal muscle: an ultrastructural
study. Anatomical Rec 252: 49–63, 1998.
Review
H336 SKELETAL MUSCLE ANGIOGENESIS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00635.2015 • www.ajpheart.org
